Research Analysts’ Recent Ratings Updates for National HealthCare (NHC)

A number of research firms have changed their ratings and price targets for National HealthCare (NYSEAMERICAN: NHC):

• 5/18/2026 – National HealthCare was upgraded by Royal Bank Of Canada to “hold”.
• 5/18/2026 – National HealthCare was upgraded by The Goldman Sachs Group, Inc. to “strong-buy”.
• 5/18/2026 – National HealthCare was upgraded by BMO Capital Markets to “hold”.
• 5/18/2026 – National HealthCare was upgraded by Robert W. Baird to “strong-buy”.

National HealthCare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.3%. This is an increase from National HealthCare’s previous quarterly dividend of $0.64. The ex-dividend date of this dividend is Tuesday, June 30th. National HealthCare’s payout ratio is 59.12%.

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.